SV40 mediates stable gene transfer in vivo

Gene Therapy

Volumn 3, Issue 7, 1996, Pages 581-587

  Strayer, D S ^a   Milano, J ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Gene therapy; Viral vectors

Indexed keywords

LUCIFERASE; VIRUS DNA; VIRUS LARGE T ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; BRAIN; COLON; GENE THERAPY; GENE TRANSFER; HEMATOPOIETIC CELL; IMMUNOCHEMISTRY; INOCULATION; KIDNEY; LIVER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; SIMIAN VIRUS 40; SKIN; SPLEEN; VIRUS REPLICATION;

ANIMALS; CELL LINE; COS CELLS; FEMALE; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEMATOPOIETIC STEM CELLS; INJECTIONS, INTRAVENOUS; LUCIFERASES; MICE; MICE, INBRED BALB C; SIMIAN VIRUS 40; VIRUS REPLICATION;

ANIMALIA; DNA VIRUSES; MURINAE; SIMIAE; SIMIAN VIRUS; SIMIAN VIRUS 40;

EID: 0029781633     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Brody SL, Crystal RG. Adenovirus-mediated in vivo gene transfer. Ann NY Acad Sci 1994; 716: 90-101.
2. Litzinger DC, Huang L. Phosphatidylethanolamine liposomes: drug delivery, gene transfer and immunodiagnostic applications. Biochem Biophys Acta 1992; 1113: 201-227.
3. Vile RG, Russell SJ. Retroviruses as vectors. Br Med Bull 1995; 51: 12-30.
4. Eckhart W. Polyomavirinae and their Replication. In: Fields BN et al (eds). Virology. Raven Press: New York, 1990, pp 1593-1607.
5. Perbal BV, Linke HK, Fareed GC. Molecular Biology of Polyomaviruses and Herpesviruses. John Wiley and Sons: New York, 1983.
6. Chia W, Rigby PW. Fate of viral DNA in nonpermissive cells infected with simian virus 40. Proc Natl Acad Sci USA 1981; 78: 6638-6642.
7. Stringer JR. Integrated simian virus 40 DNA: nucleotide sequences at cell-virus recombinant junctions. J Viral 1981; 38: 671-679.
8. Bryan TM, Reddel RR. SV40-induced immortalization of human cells. Crit Rev Oncogen 1994; 5: 331-357.
9. Tooze J (ed). DNA Tumor Viruses, Molecular Biology of Tumor Viruses, 2nd edn. Cold Spring Harbor Laboratory: Cold Spring Harbor, NY, 1981.
10. Monier R, Salzman NP. History and overview of oncogenic DNA viruses. In Phillips LA (ed). Viruses Associated with Human Cancer. Marcel Dekker New York, 1983, pp 3-36.
11. Gooding LR. Specificities of killing by cytotoxic lymphocytes generated in vivo and in vitro to syngeneic SV40 transformed cells. J Immunol 1977; 118: 920-927.
12. Butel JS, Jarvis DL. The plasma-membrane-associated form of SV40 large tumor antigen: biochemical and biological properties Biochim Biophys Acta 1986; 865: 171-195.
13. Alwine JC et al Analysis of the mechanism of trans-activation mediated by simian virus 40 large T antigen and other viral trans-acting proteins. Viruses and Human Cancer. Alan R Liss: New York, 1987, pp 269-281.
14. Bennett ER, Naujokas M, Hassell JA. Requirements for species-specific papovavirus DNA replication. J Virol 1989; 63: 5371-5385.
15. Kohn DB. The current status of gene therapy using hematopoietic stem cells. Curr Opin Pediatr 1995; 7: 56-63
16. Kotin RM. Prospects for the use of adeno-associated virus as a vector for human gene therapy. Hum Gene Ther 1994; 5: 793-801.
17. Boris-Lawrie K, Temin HM. The retroviral vector. Replication cycle and safety considerations for retrovirus-mediated gene therapy. Ann NY Acad Sci 1994; 716: 59-70.
18. Dai Y et al. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression. Proc Natl Acad Sci USA 1995; 92: 1401-1405.
19. Yang Y, Li Q, Ertl HCJ, Wilson JM. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J Virol 1994; 69: 2004-2015.
20. Smith C. Retroviral vector-mediated gene transfer into hematopoietic cells: prospects and issues. J Hematother 1992; 1: 155-166.
21. Rosenfield MA, Ronald G, Crystal RG. Gene therapy for pulmonary diseases. Pathol Biol 1993; 41: 677-680.
22. Halbert CL, Alexander IE, Wolgamot GM, Miller AD. Adeno-associated virus vectors transduce primary cells much less efficiently than immortalized cells. J Virol 1995; 69: 1473-1479.
23. Glorioso JC, Goins WF, Fink DJ, DeLuca NA. Herpes simplex virus vectors and gene transfer to the brain. Dev Biol Stand 1994; 82: 79-87.
24. Glorioso JC et al. Gene transfer to the brain using herpes simplex virus vectors. Ann Neural 1994; 35: S28-S34.
25. Goldman MJ, Litzky LA, Engelhardt JF, Wilson JM. Transfer of the CFTR gene to the lung of nonhuman primates with E1-deleted, E2a-defective recombinant adenoviruses: a preclinical toxicology study. Hum Gene Ther 1995; 6: 839-851.
26. Yee J-K et al. A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes. Proc Natl Acad Sci USA 1994; 91: 9564-9568.
27. Murphy E. Gene therapy's growing pains. Science 1995; 269: 1052-1053.
28. Gething MJ, Sambrook J. Cell-surface expression of influenza haemagglutinin from a cloned DNA copy of the RNA gene. Nature 1981; 293- 620-625.
29. Asano M, Iawakura Y, Kawade Y. SV40 vector with early gene replacement efficient m transducing exogenous DNA into mammalian cells. Nucleic Acids Res 1985; 13: 8573-8586.
30. Davis HL, Whalen RG, Demeneix BA. Direct gene transfer into skeletal muscle in vivo. factors affecting efficiency of transfer and stability of expression. Hum Gene Ther 1993; 4: 151-159.
31. Thompson JF, Hayes LS, Lloyd DB. Modulation of firefly luciferase stability and impact on studies of gene regulation. Gene 1991; 103: 171-177.
32. Mortimer EA Jr et al. Long-term follow-up of persons inadvertently inoculated with SV40 as neonates. New Engl J Med 1981; 305: 1517-1518.
33. Shah K, Nathanson N. Human exposure to SV40. review and comment. J Epidemiol 1976; 103: 1-12.
34. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: a Laboratory Manual. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, 1989.
35. Rosenberg BH, Deutsch JF, Ungers GE. Growth and purification of SV40 virus for biochemical studies. J Virol Meth 1981; 3: 167-176.
36. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981; 29: 577-580